Doubts over US government plans for COVID-19 vaccine

There are doubts about the US government's plans to have 300 million COVID-19 vaccine doses ready by the end of the year, after the front-running candidate from Moderna advanced to mid-stag

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial. 

AZ joins COVID-19 vaccine race with Oxford Uni partnership

AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July. 

No takeover approach, says COVID-19 vaccine developer BioNTe...

Germany’s BioNTech has said it has not received any takeover approaches after it began a high-profile coronavirus vaccine trial with Pfizer in Germany, following press reports over the week

Sixth COVID-19 vaccine clinical trial begins at UK's Oxford ...

The UK government is throwing £42.5 million at two potential coronavirus vaccine candidates as it steps up efforts to fight the pandemic, as Oxford University scientists began the sixth cli

Oxford Uni coronavirus vaccine trial could begin this week